Ginkgo biloba/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on activities of daily living score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“There were no statistically significant differences in ADL change scores between ginkgo and placebo, with SMD = -0.32 (95% CI -0.66; 0.03, z = 1.77, N = 6, p = 0.08) (Figure.”
Quoted verbatim from Effects of Ginkgo biloba in dementia: systematic review and meta-analysis.. - Study
- meta-analysis
- Dose
- 120-240 mg daily; where a trial studied several dose levels the higher-dose arm was used
- Population
- Adults with mild to moderate Alzheimer's disease, vascular dementia or mixed dementia, pooled across six randomised trials whose activities-of-daily-living instruments were not harmonised (GERRI, GBS-ADL, ADL-IS, NAA, NAB).
Effect -0.32 standardised mean difference, 95% CI -0.66 to 0.03
Effects of Ginkgo biloba in dementia: systematic review and meta-analysis.2010PMID:20236541Permalink
Keep reading
- Everything the graph holds on Ginkgo biloba
- Every compound studied against Activities of daily living score
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M10EA79JQS3R0RQEGQFHQ47K